Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludovic Lacroix

Showing results (81-90 of 180) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2016
Crizotinib-Resistant ROS1 Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for ROS1- and ALK-Rearranged Lung CancersFrancesco Facchinetti, Yohann Loriot, Mei-Shiue Kuo, et al.
Journal of Thoracic Disease|September 4, 2018
Endobronchial ultrasound-guided fine-needle aspiration for pulmonary carcinomas genotyping: experience with 398 cases including rapid <i>EGFR/KRAS</i> analysis in 43 casesMaria-Rosa Ghigna, Adrian Crutu, Valentina Florea, et al.
Molecular and Cellular Endocrinology|May 13, 2014
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumoursMarialuisa Sponziello, Cosimo Durante, Amelie Boichard, et al.
Lung Cancer (Amsterdam, Netherlands)|December 26, 2021
Gefitinib plus tremelimumab combination in refractory non-small cell lung cancer patients harbouring EGFR mutations: The GEFTREM phase I trialMariona Riudavets, Marie Naigeon, Matthieu Texier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in <i>ALK</i>-Rearranged Non-Small-Cell Lung CancerEmma Pailler, Vincent Faugeroux, Marianne Oulhen, et al.
NPJ Precision Oncology|October 7, 2024
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trialsArnaud Bayle, Laila Belcaid, Sophie Cousin, et al.
Endocrine Pathology|October 29, 2025
Performance of Immunohistochemistry to Detect Rb/p53 Alterations in High-Grade Neuroendocrine Neoplasms: Staining Patterns and Comparison with Genetic TestingRuiqian Chen, Matthieu Tihy, Ludovic Lacroix, et al.
Anticancer Research|May 2, 2018
First French Pilot Quality Assessment of the EndoPredict Test for Early Luminal Breast CarcinomaJacqueline Lehmann-Che, Catherine Miquel, Jennifer Wong, et al.
Plos One|June 22, 2012
Attenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-α by restoring p53 functionJane Muret, Meriem Hasmim, Izabela Stasik, et al.
Cancer|June 2, 2024
Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancerFélix Blanc-Durand, Geraldine M Camilleri, Arnaud Bayle, et al.
Pageof 18

Showing results (81-90 of 180) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2016
Crizotinib-Resistant ROS1 Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for ROS1- and ALK-Rearranged Lung CancersFrancesco Facchinetti, Yohann Loriot, Mei-Shiue Kuo, et al.
Journal of Thoracic Disease|September 4, 2018
Endobronchial ultrasound-guided fine-needle aspiration for pulmonary carcinomas genotyping: experience with 398 cases including rapid <i>EGFR/KRAS</i> analysis in 43 casesMaria-Rosa Ghigna, Adrian Crutu, Valentina Florea, et al.
Molecular and Cellular Endocrinology|May 13, 2014
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumoursMarialuisa Sponziello, Cosimo Durante, Amelie Boichard, et al.
Lung Cancer (Amsterdam, Netherlands)|December 26, 2021
Gefitinib plus tremelimumab combination in refractory non-small cell lung cancer patients harbouring EGFR mutations: The GEFTREM phase I trialMariona Riudavets, Marie Naigeon, Matthieu Texier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in <i>ALK</i>-Rearranged Non-Small-Cell Lung CancerEmma Pailler, Vincent Faugeroux, Marianne Oulhen, et al.
NPJ Precision Oncology|October 7, 2024
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trialsArnaud Bayle, Laila Belcaid, Sophie Cousin, et al.
Endocrine Pathology|October 29, 2025
Performance of Immunohistochemistry to Detect Rb/p53 Alterations in High-Grade Neuroendocrine Neoplasms: Staining Patterns and Comparison with Genetic TestingRuiqian Chen, Matthieu Tihy, Ludovic Lacroix, et al.
Anticancer Research|May 2, 2018
First French Pilot Quality Assessment of the EndoPredict Test for Early Luminal Breast CarcinomaJacqueline Lehmann-Che, Catherine Miquel, Jennifer Wong, et al.
Plos One|June 22, 2012
Attenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-α by restoring p53 functionJane Muret, Meriem Hasmim, Izabela Stasik, et al.
Cancer|June 2, 2024
Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancerFélix Blanc-Durand, Geraldine M Camilleri, Arnaud Bayle, et al.
Pageof 18